ANI PHARMACEUTICALS, INC Repayments of Debt
ANI PHARMACEUTICALS, INC (ANIP) reported Repayments of Debt of $1.50 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2024-08-06
- ANI PHARMACEUTICALS, INC repayments of debt for the quarter ending 2024-06-30 was $750.00K, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC repayments of debt for the quarter ending 2024-03-31 was $750.00K, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC repayments of debt for the quarter ending 2023-12-31 was $750.00K, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC repayments of debt for the quarter ending 2023-09-30 was $750.00K, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC repayments of debt for fiscal 2023 was $3.00M, a 0.00% change from fiscal 2022.
- ANI PHARMACEUTICALS, INC repayments of debt for fiscal 2022 was $3.00M.
- ANI PHARMACEUTICALS, INC repayments of debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- ANI PHARMACEUTICALS, INC repayments of debt for fiscal 2020 was $8.03M.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2024-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.50M 10-Q · filed 2024-08-06 | $2.25M derived: sum of 3 quarters · filed 2024-08-06 | $3.00M derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | $750.00K 10-Q · filed 2024-05-10 | $1.50M derived: sum of 2 quarters · filed 2024-05-10 | $2.25M derived: sum of 3 quarters · filed 2024-05-10 | $3.00M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.50M derived: sum of 2 quarters · filed 2024-02-29 | $2.25M derived: sum of 3 quarters · filed 2024-08-06 | $3.00M 10-K · filed 2024-02-29 |
| 2023-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.50M derived: sum of 2 quarters · filed 2024-08-06 | $2.25M 10-Q · filed 2023-11-08 | $3.00M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.50M 10-Q · filed 2024-08-06 | $2.25M derived: sum of 3 quarters · filed 2024-08-06 | $3.00M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $750.00K 10-Q · filed 2024-05-10 | $1.50M derived: sum of 2 quarters · filed 2024-05-10 | $2.25M derived: sum of 3 quarters · filed 2024-05-10 | $3.00M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.50M derived: sum of 2 quarters · filed 2024-02-29 | $2.25M derived: sum of 3 quarters · filed 2024-02-29 | $3.00M 10-K · filed 2024-02-29 |
| 2022-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.50M derived: sum of 2 quarters · filed 2023-11-08 | $2.25M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.50M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $750.00K 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $8.03M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |